Anti-MEK1 antibody [E342]
- 20ul selling size
- KO Validated
- RabMAb
- Recombinant
- What is this?
5
(5 Reviews)
|
(65 Publications)
Knockout Tested Rabbit Recombinant Monoclonal MEK1 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 65 publications.
View Alternative Names
MEK1, PRKMK1, MAP2K1, Dual specificity mitogen-activated protein kinase kinase 1, MAP kinase kinase 1, MAPKK 1, MKK1, ERK activator kinase 1, MAPK/ERK kinase 1, MEK 1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-MEK1 antibody [E342] (AB32091)
Overlay histogram showing HeLa cells stained with ab32091 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32091, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MEK1 antibody [E342] (AB32091)
ab32091, at a 1/100 dilution, staining MEK1 in paraffin embedded human cervical carcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-MEK1 antibody [E342] (AB32091)
Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling MEK1 with purified ab32091 at dilution of 1/500. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Nuclei were counterstained with DAPI (blue).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control.
- WB
Lab
Western blot - Anti-MEK1 antibody [E342] (AB32091)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : MEK1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : A431 whole cell lysate (20 μg)
Lane 4 : HepG2 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32091 observed at 43 kDa. Red - loading control, ab18058, observed at 130 kDa.
ab32091 was shown to specifically react with MEK1 in wild-type HAP1 cells as signal was lost in MEK1 knockout cells. Wild-type and MEK1 knockout samples were subjected to SDS-PAGE. ab32091 and ab18058 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-MEK1 antibody [E342] (ab32091)
Predicted band size: 43 kDa
false
- WB
Lab
Western blot - Anti-MEK1 antibody [E342] (AB32091)
Blocking/Diluting buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-MEK1 antibody [E342] (ab32091) at 1/5000 dilution
All lanes:
A431 (Human epidermoid carcinoma epithelial cell)whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 45 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-MEK1 antibody [E342] (AB32091)
Western blot : Anti-MAP2K1 antibody [E342] (ab32091) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab32091 was shown to bind specifically to MAP2K1. A band was observed at 45 kDa in wild-type A549 cell lysates with no signal observed at this size in MAP2K1 knockout cell line. To generate this image, wild-type and MAP2K1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-MEK1 antibody [E342] (ab32091) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
MAP2K1 knockout A549 cell lysate at 20 µg
Lane 3:
Wild-type HAP1 cell lysate at 20 µg
Lane 4:
MAP2K1 knockout HAP1 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 43 kDa
Observed band size: 45 kDa
false
Related conjugates and formulations (5)
-
Anti-MEK1 antibody [E342] - BSA and Azide free (Detector)
-
Anti-MEK1 antibody [E342] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MEK1 antibody [E342]
-
HRP Anti-MEK1 antibody [E342]
-
578 PE
PE Anti-MEK1 antibody [E342]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MEK1 impacts cell processes such as proliferation differentiation and survival. It does not work alone but forms a complex with other proteins to exert its function. MEK1 activity is tightly controlled by upstream activators and downstream targets. One of the key phosphorylation sites on MEK1 is at serine 298 often marked as MEK1 pS298. This phosphorylation indicates MEK1's activated state which is critical for its biological function.
Pathways
MEK1 integrates signals within the MAPK/ERK pathway and interacts closely with RAF kinases upstream and ERK kinases downstream. This pathway modulates cellular responses to growth factors. MEK1 undergoes phosphorylation enhancing its activity and subsequently phosphorylates ERK proteins. Many studies isolate MEK1 activity using specific inhibitors such as the MEK1 inhibitor to dissect pathway dynamics. ERK inhibitor PD98059 also helps when studying parallel interactions with MEK1.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (65)
Recent publications for all applications. Explore the full list and refine your search
CytoJournal 21:65 PubMed39917003
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 13:6347-6363 PubMed39697757
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules & biomedicine 25:1023-1037 PubMed39319867
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23848 PubMed39264832
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 13:4159-4171 PubMed39262478
2024
Applications
Unspecified application
Species
Unspecified reactive species
Disease models & mechanisms 17: PubMed38826084
2024
Applications
Unspecified application
Species
Unspecified reactive species
Photochemistry and photobiology 100:622-632 PubMed37732548
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:9938-9951 PubMed37522357
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 49: PubMed37165929
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36674593
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com